|
|
|
|
Pharmacokinetic-Pharmacodynamic Assessment of Faropenem in a Lethal Murine-Bacillus anthracis Inhalation Post-Exposure Prophylaxis Model [Article]
Pharmacokinetic-Pharmacodynamic Assessment of Faropenem in a Lethal Murine-Bacillus anthracis Inhalation Post-Exposure Prophylaxis Model Stanley C.Gill*, Christopher M. Rubino, Jennifer Bassett, Lynda Miller, Paul G. Ambrose, Sujata M. Bhavnani, Amber...
|
|
|
Daiichi Sankyo to launch innovator products in Mexico
Daiichi Sankyo Company (Daiichi Sankyo) and Ranbaxy Laboratories Mexico have agreed to commercialize Daiichi Sankyo's innovator products olmesartan medoxomil, an antihypertensive discovered by Daiichi Sankyo, in Mexico.Additionally, the companies...
|
|
|
Benicar(R) for the Treating High Blood Pressure in Children aged 6-16 Approved by FDA
Resources for Food and Drug Administration (FDA) asahi.com U.S.Food and Drug Administration (FDA) has approved the hypertension treatment Benicar(R) (olmesartan medoxomil) for use in children and adolescents 6 to 16 years of age, announced by...
|
|
|
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
Chrysant SG et al.Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension.
|
|
|
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
Journal of Human Hypertension advance online publication, February 18, 2010.Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension.
|
|
|
FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16
New Treatment Option Available for the Rapidly Growing Population of Children Suffering From High Blood Pressure PARSIPPANY, N.J., Feb.11 (HSMN NewsFeed) -- Daiichi Sankyo, Inc. announced today that the U.S. Food and Drug Administration (FDA) has...
Healthcare Sales & Marketing Network:
Feb 18 2010 2:37AM
Matching: olmesartan medoxomil
|
Find similar documents
|
|
|
|
Blood pressure medication approved for children
(HealthDay News) Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S.Food and Drug Administration to treat the same condition in children aged 6 to 16, drug maker Daiichi Sankyo...
|
|
|
Benicar approved for kids with high blood pressure
THURSDAY, Feb.11 (HealthDay News) -- Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16,...
|
|
|
FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16
New Treatment Option Available for the Rapidly Growing Population of Children Suffering From High Blood Pressure PARSIPPANY, N.J., Feb.11 /PRNewswire/ -- Daiichi Sankyo, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved...
|
|
|
FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16(1)
New Treatment Option Available for the Rapidly Growing Population of Children Suffering From High Blood Pressure(2) Parsippany, NJ - February 11, 2010 - Daiichi Sankyo, Inc.announced today that the U.S. Food and Drug Administration (FDA) has approved the...
|
|
|
FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents aged 6-16(1)
For more information, please contact: Alyssa Dargento Daiichi Sankyo, Inc.(973) 944-2913 (973) 727-1604 (cell) adargento@dsi.com Matthew Gold Hill & Knowlton, Inc. (212) 885-0564 (631) 804-3639 matthew.gold@hillandknowlton.com FDA Approves Benicar for...
|
|
|
Benicar Approved for Kids With High Blood Pressure
THURSDAY, Feb.11 (HealthDay News) -- Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16,...
|
|
|
FDA Approves Benicar(R) for the Treatment of High Blood Pressure in Children and Adolescents ...
New Treatment Option Available for the Rapidly Growing Population of Children Suffering From High Blood Pressure PARSIPPANY, NJ, USA | February 11, 2010 | Daiichi Sankyo, Inc.announced today that the U.S. Food and Drug Administration (FDA) has approved the...
|
|
|
FDA Approves Olmesartan Medoxomil for Hypertension in Children, Adolescents
-- The US Food and Drug Administration (FDA) has approved olmesartan medoxomil (Benicar), alone or with other antihypertensive agents, for use in children and adolescents aged 6 to 16 years with hypertension.The approval was based on a phase 3...
|
|
|
Benicar approved for kids with high blood pressure
THURSDAY, Feb.11 (HealthDay News) -- Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16,...
|
|
|
Benicar approved for kids with high blood pressure
THURSDAY, Feb.11 (HealthDay News) -- Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16,...
|
|
|
Benicar approved for kids with high blood pressure
THURSDAY, Feb.11 (HealthDay News) -- Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16,...
|
|
|
Benicar approved for kids with high blood pressure
THURSDAY, Feb.11 (HealthDay News) -- Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16,...
|
|
|
Benicar Approved for Kids With High Blood Pressure
THURSDAY, Feb.11 (HealthDay News) -- Olmesartan medoxomil (Benicar), approved in 2002 to treat in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16, drug maker Daiichi...
|
|
|
Benicar approved for kids with high blood pressure
THURSDAY, Feb.11 (HealthDay News) -- Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16,...
|
|
|
Medical News: FDA Approves Benicar(R) For The Treatment Of High Blood Pressure In Children And Adolescents Aged 6-16
Daiichi Sankyo, Inc.announced that the U.S. Food and Drug Administration (FDA) has approved the hypertension treatment Benicar (olmesartan medoxomil) for use in children and adolescents 6 to 16 years of age.(1) Benicar was originally approved...
|
|
|
FDA Approves Benicar(R) For The Treatment Of High Blood Pressure In Children And Adolescents Aged 6-16
Daiichi Sankyo, Inc.announced that the U.S. Food and Drug Administration (FDA) has approved the hypertension treatment Benicar (olmesartan medoxomil) for use in children and adolescents 6 to 16 years of age.(1) Benicar was originally approved...
|
|
|
Benicar approved for kids with high blood pressure
THURSDAY, Feb.11 (HealthDay News) -- Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16,...
|
|
|
Benicar approved for kids with high blood pressure
THURSDAY, Feb.11 (HealthDay News) -- Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16,...
|
|
|
Benicar approved for kids with high blood pressure
THURSDAY, Feb.11 (HealthDay News) -- Olmesartan medoxomil (Benicar), approved in 2002 to treat high blood pressure in adults, has been sanctioned by the U.S. Food and Drug Administration to treat the same condition in children aged 6 to 16,...
|
